BELGRADE, Mont., Aug. 23, 2011 /PRNewswire/ — Bacterin
International Holdings, Inc. (NYSE Amex:
BONE), a leader in the development of revolutionary bone graft
material and antimicrobial coatings for medical applications, has
been invited to present at the Rodman & Renshaw Annual Global
Investment Conference. The conference will be held at The Waldorf
Astoria Hotel in New York City on September 11-13, 2011.
Bacterin’s chairman and CEO, Guy Cook, and CFO, John Gandolfo,
are scheduled to present on Monday, September 12, 2011 at 1:35 p.m.
Eastern time, with one-on-one meetings held throughout the day.
Management will discuss the company’s business plan and objectives
for the remainder of 2011.
The presentation will be available via webcast at www.wsw.com/webcast/rrshq20/bone.
A replay link will also be available for 90 days following the live
presentation on the company’s website at www.bacterin.com.
Bacterin recently reported record revenue for the second quarter
2011 of $7.5 million, up 25% sequentially and 135% year-over-year.
The company also reported its first positive EBITDA quarter of
For more information about the conference or to schedule a
one-on-one meeting with Bacterin management, contact your Rodman
& Renshaw representative or the conference desk at
About Bacterin International Holdings
Bacterin International Holdings, Inc. (NYSE Amex: BONE) develops,
manufactures and markets biologics products to domestic and
international markets. Bacterin’s proprietary methods optimize the
growth factors in human allografts to create the ideal stem cell
scaffold to promote bone, subchondral repair and dermal growth.
These products are used in